Zymtronix

About:

Zymtronix develops a patented platform technology that allows innovative and efficient enzyme processes.

Website: http://zymtronix.com/

Twitter/X: zymtronix

Top Investors: National Science Foundation

Description:

Zymtronix develops technology for enzyme immobilization. It provides a platform to immobilize enzymes and screen for immobilized enzyme performance, the unlocked potential of oxidative enzymes for biocatalysis, and new materials and customer-oriented processes for small molecule conversion. The company is optimizing enzyme immobilization to create unique, and sustainable and responsible processes for high-performance biocatalysis. Stéphane Corgié founded Zymtronix in 2013. It has its headquarters in Ithaca in New York.